YU21204A - Koriscenje lh u kontrolisanoj hiperstimulaciji ovarijuma - Google Patents
Koriscenje lh u kontrolisanoj hiperstimulaciji ovarijumaInfo
- Publication number
- YU21204A YU21204A YU21204A YUP21204A YU21204A YU 21204 A YU21204 A YU 21204A YU 21204 A YU21204 A YU 21204A YU P21204 A YUP21204 A YU P21204A YU 21204 A YU21204 A YU 21204A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- ovarian hyperstimulation
- controlled ovarian
- coh
- day
- controlled
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Ovaj pronalazak opisuje jednu novu upotrebu LH, i analoga koji imaju aktivnost LH, da se pomogne foliklulogeneza kod kontrolisane hiperstimulacije ovarijuma (COH), gde se LH ili njegov analog daju tokom perioda uvođenja koji traje od prvog dana do oko četvrtog stimulatorne faze u COH. [The invention provides a new use for LH, and analogues having LH-activity, for aiding folliculogenesis in controlled ovarian hyperstimulation (COH), in which the LH or an analogue thereof is administered during a priming period lasting from day 1 to about day 4 of the stimulatory phase in COH.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01307755 | 2001-09-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU21204A true YU21204A (sh) | 2006-08-17 |
| RS51505B RS51505B (sr) | 2011-06-30 |
Family
ID=8182260
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7341989B2 (sh) |
| EP (1) | EP1434600B1 (sh) |
| JP (1) | JP2005504072A (sh) |
| KR (1) | KR20040032953A (sh) |
| CN (1) | CN1302806C (sh) |
| AR (1) | AR036591A1 (sh) |
| AT (1) | ATE427755T1 (sh) |
| AU (1) | AU2002331939B2 (sh) |
| BR (1) | BR0212502A (sh) |
| CA (1) | CA2457067A1 (sh) |
| CY (1) | CY1110487T1 (sh) |
| DE (1) | DE60231892D1 (sh) |
| DK (1) | DK1434600T3 (sh) |
| EA (1) | EA009210B1 (sh) |
| ES (1) | ES2322136T3 (sh) |
| HK (1) | HK1067866A1 (sh) |
| HR (1) | HRP20040070A2 (sh) |
| IL (1) | IL160781A0 (sh) |
| ME (1) | MEP38808A (sh) |
| MX (1) | MXPA04002125A (sh) |
| NO (1) | NO327154B1 (sh) |
| PL (1) | PL205472B1 (sh) |
| PT (1) | PT1434600E (sh) |
| RS (1) | RS51505B (sh) |
| SI (1) | SI1434600T1 (sh) |
| UA (1) | UA78970C2 (sh) |
| WO (1) | WO2003022301A2 (sh) |
| ZA (1) | ZA200401008B (sh) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050058285A (ko) * | 2002-06-07 | 2005-06-16 | 아레스 트레이딩 에스.에이. | 조절된 난소 과자극 방법 및 이런 방법에 이용되는제약학적 키트 |
| US20040248784A1 (en) * | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
| CN102296047B (zh) * | 2011-08-13 | 2013-03-13 | 新疆农垦科学院 | 利用羔羊超排卵母细胞生产体外胚胎的方法 |
| US20150272622A1 (en) | 2011-12-22 | 2015-10-01 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
| US9282995B2 (en) * | 2011-12-22 | 2016-03-15 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
| US9216037B2 (en) | 2013-06-21 | 2015-12-22 | Previvo Genetics, Llc | Uterine lavage for embryo retrieval |
| US20160024181A1 (en) | 2013-03-13 | 2016-01-28 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| RU2629871C1 (ru) * | 2016-03-22 | 2017-09-04 | Сергей Михайлович Юдин | Препарат для стимуляции фолликулогенеза и способ его применения |
| IT202000022015A1 (it) * | 2020-09-18 | 2022-03-18 | Marca Antonio La | Nuovo uso dell'ormone luteinizzante |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4589402A (en) | 1984-07-26 | 1986-05-20 | Serono Laboratories, Inc. | Method of in vitro fertilization |
| IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
| WO2000067778A1 (en) * | 1999-05-07 | 2000-11-16 | Applied Research Systems Ars Holding N.V. | Gonadotrophins |
-
2002
- 2002-09-12 KR KR10-2004-7002589A patent/KR20040032953A/ko not_active Application Discontinuation
- 2002-09-12 ME MEP-388/08A patent/MEP38808A/xx unknown
- 2002-09-12 PT PT02767637T patent/PT1434600E/pt unknown
- 2002-09-12 ES ES02767637T patent/ES2322136T3/es not_active Expired - Lifetime
- 2002-09-12 AR ARP020103455A patent/AR036591A1/es not_active Application Discontinuation
- 2002-09-12 PL PL367343A patent/PL205472B1/pl unknown
- 2002-09-12 US US10/487,423 patent/US7341989B2/en not_active Expired - Fee Related
- 2002-09-12 DE DE60231892T patent/DE60231892D1/de not_active Expired - Lifetime
- 2002-09-12 CN CNB028175743A patent/CN1302806C/zh not_active Expired - Fee Related
- 2002-09-12 MX MXPA04002125A patent/MXPA04002125A/es active IP Right Grant
- 2002-09-12 WO PCT/GB2002/004147 patent/WO2003022301A2/en active Application Filing
- 2002-09-12 EP EP02767637A patent/EP1434600B1/en not_active Revoked
- 2002-09-12 AT AT02767637T patent/ATE427755T1/de active
- 2002-09-12 EA EA200400428A patent/EA009210B1/ru not_active IP Right Cessation
- 2002-09-12 AU AU2002331939A patent/AU2002331939B2/en not_active Ceased
- 2002-09-12 RS YUP-212/04A patent/RS51505B/sr unknown
- 2002-09-12 JP JP2003526429A patent/JP2005504072A/ja active Pending
- 2002-09-12 SI SI200230815T patent/SI1434600T1/sl unknown
- 2002-09-12 BR BR0212502-1A patent/BR0212502A/pt not_active Application Discontinuation
- 2002-09-12 IL IL16078102A patent/IL160781A0/xx unknown
- 2002-09-12 DK DK02767637T patent/DK1434600T3/da active
- 2002-09-12 CA CA002457067A patent/CA2457067A1/en not_active Withdrawn
- 2002-12-09 UA UA2004031858A patent/UA78970C2/uk unknown
-
2004
- 2004-01-23 HR HR20040070A patent/HRP20040070A2/hr not_active Application Discontinuation
- 2004-02-06 ZA ZA2004/01008A patent/ZA200401008B/en unknown
- 2004-03-08 NO NO20040990A patent/NO327154B1/no not_active IP Right Cessation
-
2005
- 2005-02-22 HK HK05101453A patent/HK1067866A1/xx not_active IP Right Cessation
-
2009
- 2009-06-30 CY CY20091100694T patent/CY1110487T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0946191T3 (da) | Anvendelse af GLP-1-analoge og -derivater indgivet perifert til regulering af fedme | |
| CY1110487T1 (el) | Χρηση της lh σε ελεγχομενη υπερδιεγερση των ωοθηκων | |
| EP2022505A3 (en) | GLP-1, exendin-4, peptide analogs and uses thereof | |
| DK0736039T3 (da) | Forbindelser med væksthormon-frigivende egenskaber | |
| CL2003001743A1 (es) | Compuestos derivados de leucinamida, inhibidores de la cisteina proteasa; composicion farmaceutica; procedimiento de preparacion de la composicion farmaceutica; y su uso en el tratamiento de la osteoporosis, enfermedad de paget's, peridontal, perdida | |
| AP9901686A0 (en) | Peptide parathyroid hormone analogs. | |
| ATE288444T1 (de) | Dipeptide, die die ausschüttung von wachstumshormonen stimulieren | |
| EA200000748A1 (ru) | Способ введения мономерных аналогов инсулина | |
| ITPD920071A1 (it) | Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo | |
| DE60110054D1 (en) | Cardioprotektive phosphonate | |
| HK1070816A1 (en) | Use of human parathyroid hormone | |
| AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
| AU3780901A (en) | Pharmaceutical composition for muscular anabolism | |
| WO2005072277A3 (en) | Amidated parathyroid hormone fragments and uses thereof | |
| NZ531018A (en) | 5-CNAC as oral delivery agent for parathyroid hormone fragments | |
| ATE238986T1 (de) | 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga | |
| EP0446313A4 (en) | Fusion proteins | |
| DE69221725D1 (de) | Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen | |
| BR0212447A (pt) | Uso de hcg e lh na hiperestimulação ovariana controlada | |
| DE60318749D1 (de) | Paralytisches peptide von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten | |
| WO2003099849A3 (en) | Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy | |
| ITTO20020684A1 (it) | Nuovo uso dell'angelicina e di suoi analoghi strutturali. | |
| MXPA06000460A (es) | Polipeptidos humanos, recombinantes, mejorados de interferon-beta-1b. | |
| ATE398134T1 (de) | Neue analoga von nitrobenzylthioinosin | |
| MX9206732A (es) | Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas de tierra. |